Trials / Completed
CompletedNCT02368743
QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 117 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This national, observational and multicentre study aims at establishing a picture of real clinical practices management among patients treated with Pentasa®, according to the current therapeutic strategy in proctitis or distal proctosigmoiditis. This study should be able to provide data on patients' health related quality of life, compliance and efficacy in real clinical practice
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mesalazine |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2017-03-01
- Completion
- 2018-01-02
- First posted
- 2015-02-23
- Last updated
- 2018-07-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02368743. Inclusion in this directory is not an endorsement.